Recommendations issued for managing chronic constipation
By
HealthDay News
Sep 13, 2024
Six strong recommendations were developed, including initial management of dietary modifications and ensuring adequate fluid and fiber intake.
Timing of blood pressure meds has no impact on outcomes
By
Haymarket Media
Sep 10, 2024
The findings were seen for both primary care patients with hypertension and nursing home residents.
Weekly mobile phone use increases risk for new cardiovascular disease over time
By
Haymarket Media
Sep 05, 2024
The association was partly explained by poor sleep, psychologic distress and neuroticism.
Dietary vitamin E may be protective against atopic dermatitis
By
Haymarket Media
Aug 30, 2024
Vitamin C, retinol and carotene are not causally tied to atopic dermatitis.
Apple will sell AirPods with hearing aids built in
By
Haymarket Media
Sep 10, 2024
It’s designed as an over-the-counter hearing aid feature for those with mild to moderate hearing loss.
High, long-term consumption of caffeine may pose cardiovascular risk
By
Haymarket Media
Aug 30, 2024
An impaired recovery of heart rate and blood pressure following physical exertion was seen in healthy adults.
Long-term cognitive benefits of sports outweigh concussion risks
By
Haymarket Media
Sep 06, 2024
The analysis included 15,214 community-dwelling adults aged 50 to 90 years followed annually for four years. The potential protective benefits on cognition were seen even in those self-reporting a history...
Asthma inhalers tied to large greenhouse gas emissions production
By
Haymarket Media
Sep 04, 2024
Metered-dose inhalers were responsible for almost all inhaler-related emissions.
Inflammation, cholesterol, lipoprotein(a) predict 30-year cardiovascular outcomes in women
By
Haymarket Media
Sep 03, 2024
The authors say that the findings call for primary prevention strategies to extend beyond traditional 10-year estimates.
RSV infection with inflammatory bowel disease ups risk for hospitalization
By
Haymarket Media
Aug 28, 2024
“Adult patients with IBD and RSV infection … may benefit from the new RSV vaccine recommended for adults aged 60 years and older,” the authors write.